Search results for: 'level sensor'

This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast by segment, drivers and restraints, and technology trends, along with the competitive factors and strategies, and key companies to watch. The global market is primarily driven by the high prevalen...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

The digital health industry has maintained a consistent growth trajectory. Investing in technologies that help organizations achieve the quintuple aim of healthcare is a constant priority. However, high inflation and tight monetary policy will impact the investment landscape as it shifts from top-line growth to profitability. The use of AI tech...

16 Feb 2021  |  North America  |  Market Research

Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market

Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care

Infographics

×

Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...

Laboratory personnel were invited to participate in an online survey in June 2014. A total of 366 laboratory decision makers qualified to complete the survey, answering questions about their use of laboratory information management systems (LIMS). Respondents organization types include academic laboratory or core facility; federal, state, or local...

This research service pertains to the US market for medical radiopharmaceuticals. A thorough market sizing and forecasting model of market revenue, procedure volumes, and average pricing is included, along with analyses of market trends, drivers and restraints, and the reimbursement and the competitive environments at the total level as well as wit...

This research service evaluates the U.S. MRI systems market during the 2008 to 2016 time period. It provides analyses of the less than or equal to 1.5 Tesla and 3.0 Tesla market segments at the total market and individual segment levels. Content in this research service includes market background, technology trends, market drivers and restraints, a...

This research service pertains to the US market for nuclear medicine and positron emission tomography (PET) imaging systems. Providing thorough market sizing and forecast of market revenue, unit shipments, procedure volumes, average pricing, and installed base, the study analyzes market trends, drivers and restraints, along with the reimbursement a...

The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to val...